Anti-Intercellular Adhesion Molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice

Lupus

Volumn 6, Issue 8, 1997, Pages 645-651

  Brey, R L ^a   Amato, A A ^a   Kagan Hallet, K ^a   Rhine, C B ^a   Stall worth, C L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Intercellular adhesion molecule 1; MRL 1pr mice; Nerve conduction studies; Systemic lupus erythematosus

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; CHOROID PLEXUS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOLOGY; IMMUNOTHERAPY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MOUSE; NERVE CONDUCTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCIATIC NERVE; SKIN DISEASE; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 0030696153     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600805     Document Type: Article

References (39)

1. Kaell AT et al. The diversity of neurologic events in systemic lupus erythematosus. Arch Neurol 1986; 43: 273-276.
2. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine 1968; 47: 337-369.
3. Isenberg DA, Snaith ML. Muscle disease in systemic lupus erythematosus: a study of its nature, frequency and cause. J Rheymatol 1981; 8: 917-524.
4. Lowman EW. Muscle, nerve and synovial changes in lupus erythematosus. Ann Rheumatic Dis 1951; 10: 16-21.
5. Bluestein HG. Neuropsychiatric manifestations of systemic lupus erythematosus. In: R G Lahita (ed). Systemic Lupus Erytheratosus. Churchill Livingstone, Edinburgh 1987; pp 593-614.
6. Hickey WF. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991; 28: 254-260.
7. Raine CS et al. Homing to the central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelia cell adhesion during the initial stages of autoimmune demylination. Lab Invest 1990; 63: 476-489
8. Rossler K et al. Expression of leukocyte adhesion molecules at the human blood-brain barrier. J Neurosci Res 1992; 31: 365-374.
9. Savage COS, Cooke SP. The role of the endothelium in systemic vascuhties. J Autoimmun 1993; 6: 237-249
10. Brankin B et al. Adhesion molecule expression and lymphocyte adhesion to cerebral endothelium: effects of measles virus and herpes simplex 1 virus. J Neuroimmunol 1995; 56: 1-8
11. Zabry Z et al. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55. J Neuroimmunol 1992; 36: 1-11
12. Dopp JM, Breneman SM, Olschowka JA. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J Neuroimmunol 1994; 54: 129-144.
13. Wong D, Dorovini-Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvascular endothelial cells by cytokines and lipopolysaccharid. J Neuroimmunol 1992; 39: 11-22.
14. Belmont HM et al. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 376-383.
15. Janssen BA et al. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheum 1994; 35: 1112-1116.
16. Sfikakis PP et al. Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12: 5-9.
17. Spronk PE et al. Levels of soluble VCAM-1, soluble ICAM-1 and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus. Clin Exp Immunol 1994; 97: 439-444.
18. Brey RL, Escalante A, Cote SA. Thrombosis, anticardiolipins and soluble adhesion proteins. Stroke 1996; 27: 187(abstract).
19. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Arthritis Rheum 1996; 39: 9-22.
20. Argenbright LW, Barton RW. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited. J Clin Invest 1992; 89: 259-272.
21. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269-390.
22. Alexander EL et al. Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Arthritis Rheum 1985; 28: 1146-1155.
23. Rudick RA, Eskin TA. Neuropathological features of a lupus-like disorder in autoimmune mice. Ann Neurol 1983; 14: 325-322.
24. Alexander EL et al. Congenic autoimmune murine models of central nervous system disease in connective tissue disorders. Ann Neurol 1983; 14: 242-248.
25. Vogelweid CM et al. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J Neuroimmunol 1991; 35: 89-99.
26. 1 and MRL-lpr/lpr autoimmune mice: connective tissue disease. Arthritis Rheum 1988; 35: 806-811.
27. Sakic B et al. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun 1992; 6: 265-285.
28. Hess DC et al. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol 1993; 20: 610-617.
29. Brey RL et al. Model for the neuromuscular complications of systemic lupus erythematosus. Lupus 1995; 4: 209-212.
30. Hang Leming, Theofilopoulos AN, Dixon FJ. A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J Exp Med 1982; 155: 1690-1701.
31. Brey RL, Moore PM. Inflammatory arthritis and stroke. In: Batjer HH et al. (ed). Cerebrovascular Disease. Lippincott-Raven, New York, 1997; pp. 501-508.
32. Hery C et al. Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J Neuroimmunol 1995; 57: 101-109.
33. Davis LS et al. Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J Immunol 1995; 154: 3525-3537.
34. Muller GA, Markovic-Lipkovski J, Muller CA. Intercellular adhesion molecule-1 expression in human kidneys with glomerular nephritis. Clin Nephrol 1991; 36: 203-209.
35. Wuthrich RP, Snyder TL. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 1992; 42: 903-914.
36. Wuthrich RP et al.. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol 1990; 139: 441-450.
37. Kawaski K et al. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 1993; 150: 1074-1083.
38. Kavanaugh AF et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to anti-intercellular adhesion molecule-1. Arthritis Rheum 1994; 37: 992-999.
39. Davis LA et al. Introduction of persistent T cell hyporesponsiveness in vivo by monclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J. Immunol 1995; 154: 3525-3537.